American Heart Journal
Volume 148, Issue 1 , Pages 5-6 , July 2004

Coronary revascularization and quality of life

  • Mark A Hlatky, MD

      Affiliations

    • Donald W Reynolds Cardiovascular Clinical Research Center, Stanford University School of Medicine, Stanford, Calif, USA
    • Corresponding Author InformationReprint requests: Mark A. Hlatky, MD, Stanford University School of Medicine, HRP Redwood Bldg, Room 150, Stanford, CA 94305-5405, USA.

References 

  1. Yusuf S, Zucker D, Peduzzi P, et al.  Effect of coronary artery bypass graft surgery on survival (overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration). Lancet. 1994;344:563–570
  2. Bucher HC, Hengstler P, Schindler C, et al.  Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease (meta-analysis of randomised controlled trials). BMJ. 2000;321:73–77
  3. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction (a quantitative review of 24 randomised trials). Lancet. 2003;361:13–20
  4. Anderson HV, Cannon CP, Stone PH, et al.  One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trial. J Am Coll Cardiol. 1995;26:1643–1650
  5. Boden WE, O'Rourke RA, Crawford MH, et al.  Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med. 1998;338:1785–1792
  6. FRagmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators . Invasive compared with non-invasive treatment in unstable coronary-artery disease (FRISC II prospective randomised multicentre study). Lancet. 1999;354:708–715
  7. Cannon CP, Weintraub WS, Demopoulos LA, et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879–1887
  8. Fox KAA, Poole-Wilson PA, Henderson RA, et al.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction (the British Heart Foundation RITA 3 randomised trial). Lancet. 2002;360:743–751
  9. Barnett PG, Chen S, Boden WE, et al.  Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction (results of a randomized trial). Circulation. 2002;105:680–684
  10. Mahoney EM, Jurkovitz CT, Chu H, et al.  Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA. 2002;288:1851–1858
  11. Janzon M, Levin LA, Swahn E, et al.  Cost-effectiveness of an invasive strategy in unstable coronary artery disease (results from the FRISC II invasive trial). Eur Heart J. 2002;23:31–40
  12. CASS Principal Investigators and Their Associates . Coronary Artery Surgery Study (CASS) (a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups). Circulation. 1983;68:951–960
  13. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med. 1992;326:10–16
  14. Cobb LA, Thomas GI, Dillard DH, et al.  An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med. 1959;260:1115–1118
  15. Dimond EG, Kittle CF, Crockett JE. Comparison of internal mammary artery ligation and sham operation for angina pectoris. Am J Cardiol. 1960;5:483–486
  16. Stone GW, Teirstein PS, Rubenstein R, et al.  A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. J Am Coll Cardiol. 2002;39:1581–1587
  17. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. JAMA. 1995;273:59–65
  18. Melsop K, Boothroyd DB, Hlatky MA. Quality of life and and utility in patients with coronary artery disease. Am Heart J. 2003;145:36–41
  19. Pocock SJ, Henderson RA, Clayton T, Lyman GH, Chamberlain DA. Quality of life after coronary angioplasty or continued medical treatment for angina (Three-year follow-up in the RITA-2 trial). J Am Coll Cardiol. 2000;35:907–914
  20. Janzon M, Levin LA, Swahn E. Invasive treatment in unstable coronary artery disease promotes health-related quality of life (results from the FRISC II trial). Am Heart J. 2004;148:112–119
  21. Diderholm E, Andrén B, Frostfeldt G, et al.  Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease. Am J Med. 2003;115:606–612

PII: S0002-8703(04)00124-3

doi: 10.1016/j.ahj.2004.03.003

American Heart Journal
Volume 148, Issue 1 , Pages 5-6 , July 2004

Article Tools